Roxwood Medical Inc.
Supporting interventional treatment of arterial blockages
This article was originally published in Start Up
Executive Summary
Crossing occluded arteries with traditional catheters and guidewires is problematic because they tend to buckle, rather than penetrate occlusions. Roxwood Medical Inc. has developed products that incorporate a self-expanding stent-like scaffold that stabilizes guidewires and/or microcatheters in the center of the artery to facilitate access across complex lesions.
You may also be interested in...
SK Bioscience First To Line In Korea COVID Vaccine Race
SK Bioscience has received the world’s first approval of its in-house developed recombinant protein COVID-19 vaccine SKYCovione (GBP510), in its home market of South Korea, two years after it began development. Strong support from the domestic government and international cooperation helped pave the way.
Can Can-Fite’s Piclidenoson Put Up A Fight In Psoriasis?
Can-Fite’s A3AR agonist was inferior to Amgen’s Otezla by most efficacy measures, while Bristol Myers Squibb’s competing deucravacitinib is closer to approval and did beat Otezla.
ReCode Raises Another $120m To Broaden LNP Delivery Of Genetic Medicines
The company’s lipid nanoparticle technology can deliver mRNA, gene editing and other cargoes to multiple cell and organ types. ReCode aims to expand its pipeline beyond lung diseases.